Scribd
Upload
136 views45 pages

2011 Bioassay

A bioassay is a scientific experiment used to detect or measure the effects of a substance on a living organism. Bioassays are essential for developing new drugs and monitoring pollutants. They involve measuring the biological response of a living system, such as tissues, cells, microorganisms, or whole animals, to a specific substance. Bioassays can be qualitative, providing a "yes/no" result, or quantitative, allowing the determination of how much of the substance is needed to produce a specific effect. They are used in drug discovery, assessing pollutants, and investigating the functions of biological mediators. Common types of bioassays include in vitro, cell-based, tissue-based, and in vivo animal

Uploaded by

Farizka Dwinda H
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
136 views45 pages

2011 Bioassay

A bioassay is a scientific experiment used to detect or measure the effects of a substance on a living organism. Bioassays are essential for developing new drugs and monitoring pollutants. They involve measuring the biological response of a living system, such as tissues, cells, microorganisms, or whole animals, to a specific substance. Bioassays can be qualitative, providing a "yes/no" result, or quantitative, allowing the determination of how much of the substance is needed to produce a specific effect. They are used in drug discovery, assessing pollutants, and investigating the functions of biological mediators. Common types of bioassays include in vitro, cell-based, tissue-based, and in vivo animal

Uploaded by

Farizka Dwinda H
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
You are on page 1/ 45

BIOASSAY

NOOR WIJAYAHADI
• Bioassay = biological assay
 a type of scientific experiment
 essential in new drugs development
& monitoring pollutants
• Measure the effects of a substance on a living
organism.
•  qualitative or quantitative
• Quantitative bioassays are typically analyzed using
the methods of biostatistics
Definition
– Estimation of the conc / potency of a substance
by measuring its biological response in living
systems
– i.e.Observation of pharmacological effects on
– [1] living tissues, or cells
– [2] microorganisms
– [3] animals
Bioassays/Assays
Whole animals
Isolated organs of vertebrates
Lower organisms e.g. fungi, bacteria, insects,
molluscs, lower plants, etc.
Cultured cells such as cancer cells and tissues of
human or animal organs
Isolated sub-cellular systems, such as enzymes,
receptors, etc
The use of bioassays include:
• measurement of the pharmacological activity of new or
chemically undefined substances
• investigation of the function of endogenous mediators
• determination of the side-effect profile, including the
degree of drug toxicity
• measurement of the concentration of known
substances (alternatives to the use of whole animals
have made this use obsolete)
• assessing the amount of pollutants being released by a
particular source, such as wastewater or urban runoff.
Drug discovery
• Targets: New and Established
– Established targets  are those for which there is a
good scientific understanding
– new targets  are all those targets that are not
"established targets”
• Process  Screening and Design
Diseases- Molecular Basis
 Over- and under-expression of catalytic proteins
(enzymes)
 Toxins produced by microorganisms
 Viruses (wild DNA/molecular organisms) cause
cancers, AIDS, influenza etc.
 Mutation in DNA
 Congenital diseases due to genetic malfunctions
 Oxidation of biomolecules (proteins, carbohydrates,
lipids, nucleic acid), degenerative diseases and ageing
 Deficiency of essential elements, vitamin, nutrients etc.
I
Principles of Bioassay
• Active principle to be assayed should show the same
measured response in all animal species
• The degree of pharmacological response produced should
be reproducible under identical conditions [Eg Adrenaline
shows same rise in BP in the same species under identical
cond: wt, age, sex, strain etc]
• The reference standard must owe its activity to the
principle for which the sample is being bioassayed
• Activity assayed should be the activity of interest
• Individual variations must be minimised / accounted for
• Bioassay might measure a diff aspect of the same
substance compared to chemical assay [Eg testosterone &
metabolites
Types of Bioassays?
 In Silico Screenings
Non- physiological Assays
Biochemical or Mechanisms-Based Assays
In Vitro Assays
Cell based Bioassays
Tissue based Bioassays
In Vivo Bioassays
Animal-based Assays/Preclinical Studies
Human trial/Clinical Trials
Broad Categories of Bioassays

Virtual Screenings
Primary Bioassays
Secondary Bioassays
Preclinical Trials
Clinical Trials
Virtual Screenings

 Target Selection
 Data Mining (Chemical space of over 1060
conceivable compounds)
 Screening of Libraries of Compounds Virtually
 lead optimization
 Prediction of Structure-Activity Relationships
Primary “Bioassay/Assays”
Screenings

Non- physiological Assays


Biochemical or Mechanism-Based Assays
In Vitro Assays
Microorganism-based bioassays
Cell-based Bioassays
Tissue-based Bioassays
Examples of Primary Assays
 Antioxidant Assays
Enzyme Inhibition Assays
Cytotoxicty Bioassays
Anti-cancer Bioassays (Cancer Cell Lines)
Brine Shrimp Lethality Bioassays
In Vitro Antiparasitic Bioassays
Anti-bacterial Bioassays
Antifungal Bioassays
Insecticidal Bioassays
Phytotoxicity Bioassays
Etc.
Salient Features of Primary Bioassay
Screenings
 Predictive Potential
General in nature
Tolerant of impurities
Unbiased
High-throughput
Reproducible
Fast
Cost-effective
Compatible with DMSO
Hit Rate of Primary Bioassay
Screenings

 A hit rate of 1% or less is generally considered


a reasonable
False positive are acceptable
False negative are discouraged
Secondary Bioassays

In Vivo Bioassays


Animal-based Assays/Preclinical Studies
Predicting Drug Like Behavior- Lipinski “Rule of
Five”
• Molecular weight about 500 a. m. u. (Optimum 350)

• Number of hydrogen bond accepter ~ 10 (Optimum 5)

• Number of hydrogen bond donor ~ 5 (Optimum 2)

• Number of rotatable bonds ~5 (Conformational Flexibility)

• 1-Octanol/water partition coefficient between 2-4 range


In Vitro Bioassays

 In Vitro: In experimental situation outside the


organisms. Biological or chemical work done in
the test tube( in vitro is Latin for “in glass”) rather
than in living systems
Examples include antifungal, antibacterial,
organ-based assays, cellular assays, etc
Examples of In Vitro Bioassay
 Activity Assays
DPPH assay
Xanthine oxidase inhibition assays
Superoxide scavenging assay
Antiglycation assay
 Bioassays (cell-based)
DNA Level
Protein Level
RNA Level
Immunology assay
 Toxicity Assays
MTT assay
Cancer cell line assays
In Vivo Screenings or Pharmacological
Screenings

 In Vivo: Test performed in a living system such


as antidiabetic assays, CNS assays,
antihypertensive assays, etc.
Examples of In Vivo Bioassays

 Animal Toxicity
Acute toxicity
Chronic toxicity
 Animals Study
Animal model with induced disease
Animal model with induced injury
 Pre-Clinical Trials
 Clinical Trials
High-throughput Assays

 The process of finding a new drug against a


chosen target for a particular disease usually
involves high-throughput screening (HTS),
wherein large libraries of chemicals are tested for
their ability to modify the target.
HIGH-THROUGHPUT BIOLOGICAL
SCREENINGS

• Development of straight-forward in-vitro


biological assays (enzyme-based, cellular and
microbiological assays) into automated high-
throughput screens (HTS).
• Rapid assays of thousands or hundreds of
thousands of compounds (upto 100,000 samples
per day).
• Specifically suitable for the isolation of bioactive
constituents from complex plant extracts.
High-throughput Screening Strategy
for Enzyme Inhibition Assays
% Inhibition = [(E-S)/E]  100
Enzyme + Buffer
E = Activity of enzyme without test material
+ Potential inhibitor
S = Activity of enzyme with test material

Substrate

Incubation
Measurement of absorbance
96-well plate

12
Blood collection from the saphenous vein
Blood collection from the saphenous vein
Blood collection from the saphenous vein
making a mouse-sized tourniquet
Blood collection from the dorsal pedal vein
Retro-orbital blood collection
Proper positioning of mouse for blood collection from the jugular vein
blood collection from the jugular vein

You might also like